There are so many things to be concerned with about this stock. I really want to like it and, several times, I've contemplated taking a position.
The concerns have been too great for me to overcome though.
The concerns are: 1) Contract award date gets bumped back; 2) PositiveID doesn't win the contract due to some confluence of the good ole boy network awarding the contract to Northrop Grumman or someone else vying for it; 3) Too much light gets shed on the shortcomings of the BioWatch program and it gets squashed entirely (remember the 'virtual fence' fiasco?)
DHS's handling of these programs doesn't exactly inspire confidence.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.